Psychedelics Are Placeholders for More Traditional Depression Therapies: Analysts
Psychedelic drugs could be heading to the FDA this year, pushed along by a wave of investor and patient enthusiasm. But analysts at William Blair say these treatments are unlikely to seize the entire treatment-resistant depression (TRD) market, leaving …